menu
    • menu

    Company profile for Xeris Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Xeris is a specialty pharmaceutical company leveraging novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. Our team is focused on creating medicines that are easier to use by leveraging our unique technology. Newly approved by the FDA, Gvoke™ leverages that technology to deliver ready-to-use solutions for patients and caregivers alike. We're a specialty pharma company,...
    Xeris is a specialty pharmaceutical company leveraging novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. Our team is focused on creating medicines that are easier to use by leveraging our unique technology. Newly approved by the FDA, Gvoke™ leverages that technology to deliver ready-to-use solutions for patients and caregivers alike. We're a specialty pharma company, passionate about people. Our unique technology is enabling medicines to be easier to use for patients & caregivers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Xeris PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    180 N. Lasalle Chicago, IL 60601
    Telephone
    Telephone
    1-877-XERIS-37
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://xerispharma.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/xeris-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xeris Receive Patent Office Notice For XP-8121 Patent Application
    Xeris Receive Patent Office Notice For XP-8121 Patent Application

    01 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251201785819/en/Xeris-Announces-Notice-of-Allowance-from-U.S.-Patent-and-Trademark-Office-for-XP-8121-Patent-Application

    BUSINESSWIRE
    01 Dec 2025
    Share Share
    Xeris Bio Reports Record Q3 2025 Financial Results
    Xeris Bio Reports Record Q3 2025 Financial Results

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106200297/en/Xeris-Biopharma-Posts-Record-Financial-Results-for-the-Third-Quarter-2025

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    Xeris Bio To Release Q3 2025 Financial Results On Nov 6, 2025
    Xeris Bio To Release Q3 2025 Financial Results On Nov 6, 2025

    23 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251023312900/en/Xeris-Biopharma-to-Report-Third-Quarter-2025-Financial-Results-on-November-6-2025

    BUSINESSWIRE
    23 Oct 2025
    Share Share
    Xeris Pharma Reveals Inducement Grants Per Nasdaq LR 5635(C)(4)
    Xeris Pharma Reveals Inducement Grants Per Nasdaq LR 5635(C)(4)

    03 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251003066767/en/Xeris-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    03 Oct 2025
    Share Share
    Xeris Announces Orange Book Listing of U.S. Patent for Recorlev
    Xeris Announces Orange Book Listing of U.S. Patent for Recorlev

    25 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250825676155/en/Xeris-Announces-Orange-Book-Listing-of-U.S.-Patent-for-Recorlev

    BUSINESSWIRE
    25 Aug 2025
    Share Share
    Xeris Bio Raises Revenue Guidance After Record Q2 2025 Results
    Xeris Bio Raises Revenue Guidance After Record Q2 2025 Results

    07 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250807913489/en/Xeris-Biopharma-Reports-Record-Financial-Results-for-the-Second-Quarter-2025-and-Raises-Full-Year-Revenue-Guidance

    BUSINESSWIRE
    07 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Contact Xeris Pharmaceuticals and get a quotation

    Xeris Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of XRS0104 bulk with DMF offered by Xeris Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search